Steroid requirements during radiotherapy for malignant gliomas

Author： Marantidou Athina Levy Christine Duquesne Alyette Ursu Renata Bailon Olivier Coman Irene Belin Catherine Carpentier Antoine

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.100, Iss.1, 2010-10, pp. : 89-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas

By McKenzie Joshua

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 403-409

Springer Publishing Company

Access to resources Recommend Favorite

Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53

By Kang Hyun-Cheol Kim Chae-Yong Han Jung Choe Ghee Kim Jae Kim Jee Kim In

Journal of Neuro-Oncology, Vol. 102, Iss. 1, 2011-03 ,pp. : 157-162

Springer Publishing Company

Access to resources Recommend Favorite

Microsurgery for Malignant Gliomas

By Yaşargil M. Kadri Paulo Yaşargil Dianne

Journal of Neuro-Oncology, Vol. 69, Iss. 1-3, 2004-08 ,pp. : 67-81

Springer Publishing Company

Access to resources Recommend Favorite

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

By Banna Giuseppe Bettio Daniela Scorsetti Marta Navarria Pierina Simonelli Matteo Rodriguez Baena Riccardo Aimar Enrico Gaetani Paolo Colombo PierGiuseppe Rognone Felice Santoro Armando

Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. : 323-325

Springer Publishing Company

Access to resources Recommend Favorite

Blood-based biomarkers for malignant gliomas

By Holdhoff Matthias

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 345-352

Springer Publishing Company

Access to resources Recommend Favorite